在患有初级渐进性多发性硬化症患者的血清sTREM2水平和残疾进展
Nicolás Fissolo1,2, Pascal Benkert3,4, Andreu Vilaseca-Jolonch1
1Servei de Neurologia, Centre D'esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall D'hebron (VHIR), Hospital Universitari Vall D'hebron. Universitat Autònoma de Barcelona, Barcelona, Spain.
European journal of neurology
|January 30, 2026
概括
血清溶解TREM2 (sTREM2) 水平不能可靠地预测初级渐进性多发性硬化症 (PPMS) 的残疾进展. 这项研究在PPMS患者中发现sTREM2作为生物标志物的价值有限.
科学领域:
- 神经免疫学 神经免疫学
- 生物标志物发现发现
背景情况:
- 在骨髓细胞2 (TREM2) 上表达的触发受体是参与组织修复的微质受体.
- 在血液和CSF中溶解的TREM2 (sTREM2) 表明微质激活.
- 微质在多发性硬化症 (MS) 发病过程中发挥着关键作用.
研究的目的:
- 调查血清sTREM2水平是否可以预测初级渐进性MS (PPMS) 中的残疾进展.
主要方法:
- 在137名PPMS患者中,使用单分子阵列测定测量了血清sTREM2水平.
- 线性模型评估了 sTREM2 与扩展残疾状况表 (EDSS) 随时间变化之间的关联.
主要成果:
- 在2年后观察到sTREM2和残疾进展之间的关联,但仅在非炎症PPMS患者中.
- 在长时间的随访期间,在sTREM2水平和残疾进展之间没有发现一致的关系.
结论:
- 血清sTREM2作为预测PPMS残疾进展的生物标志物具有有限的有用性.
- 可能需要进一步的研究来探索sTREM2在特定多发性硬化症子组中的潜在作用.
相关概念视频
Tumor Progression
7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
mTOR Signaling and Cancer Progression
4.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.8K
Intellectual Disability
738
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
738
Learning Disabilities
611
Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
Dyslexia
Dyslexia is a...
611
Multiple Allele Traits
38.1K
The Concept of Multiple Allelism
38.1K
Leveling Effect
1.4K
In acid-base chemistry, the leveling effect refers to the limitation imposed by the solvent on the strength of acids and bases in solution. When a base stronger than the solvent's conjugate base is used, it deprotonates the solvent until the base is entirely consumed, making it ineffective against weaker acids. Conversely, an acid stronger than the solvent's conjugate acid protonates the solvent until the acid is depleted, rendering it ineffective against weaker bases. Essentially, the...
1.4K


